![Mark Aguillard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark Aguillard is currently the Chief Commercial Officer at DermTech, Inc. He previously held the same position at Epic Sciences, Inc. from 2021 to 2023 and at binx health, inc.
from 2020 to 2021.
Mr. Aguillard completed his undergraduate degree at Texas Tech University.
Postes actifs de Mark Aguillard
| Sociétés | Poste | Début |
|---|---|---|
| DERMTECH | Corporate Officer/Principal | 19/09/2023 |
Anciens postes connus de Mark Aguillard
| Sociétés | Poste | Fin |
|---|---|---|
Epic Sciences, Inc.
 Epic Sciences, Inc. Medical SpecialtiesHealth Technology Develops novel diagnostics to the treatment and management of cancer | Corporate Officer/Principal | 01/09/2023 |
binx health, inc.
 binx health, inc. Medical SpecialtiesHealth Technology Develops point-of-care test solutions for chlamydia and gonorrhea & related software solutions | Corporate Officer/Principal | 01/07/2021 |
Formation de Mark Aguillard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Texas Tech University
 Texas Tech University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
binx health, inc.
binx health, inc. Medical SpecialtiesHealth Technology Develops point-of-care test solutions for chlamydia and gonorrhea & related software solutions | Health Technology |
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Develops novel diagnostics to the treatment and management of cancer | Health Technology |
DermTech, Inc.
 DermTech, Inc. Medical SpecialtiesHealth Technology Provides non-invasive genomic testing services for skincare | Health Technology |
